Antimicrobial Activity of Bioactive Peptides and Their Derivatives
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antimicrobial Peptides".
Deadline for manuscript submissions: 15 June 2024 | Viewed by 485
Special Issue Editor
Interests: antimicrobial peptides; antimicrobials; host-pathogen interaction; infectious diseases; antimicrobial mechanism of action; bacterial genetics
Special Issue Information
Dear Colleagues,
The emergence and rapid spread of antimicrobial-resistant (AMR) microorganisms pose a significant global health threat. In the face of this growing challenge, there is an urgent need for novel antimicrobial agents with effective and broad-spectrum activity. Bioactive peptides (AMPs) represent a promising new class of antimicrobials that offer several advantages over traditional antibiotics. AMPs are naturally occurring peptides in various organisms, including humans, animals, plants, and microbes. They exhibit a broad spectrum of activity against several pathogens, including bacteria, fungi, and viruses.
Additionally, AMPs are less prone to developing resistance than traditional antibiotics. This Special Issue of Antibiotics will focus on the latest research on the antimicrobial activity of bioactive peptides and their derivatives. The issue will include articles on novel AMPs or their derivatives with potent antimicrobial activity, mechanisms of action of AMPs, structure–activity relationships of AMPs, development of AMP-based therapeutics, clinical applications of AMPs, and combinatory therapy with other antimicrobials.
Dr. Alexandro Rodríguez-Rojas
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial resistance (AMR)
- global health threat
- novel antimicrobial agents
- bioactive peptides (AMPs)
- natural antimicrobial agents
- broad-spectrum activity
- antimicrobial activity
- mechanisms of action
- structure–activity relationships
- AMP-based therapeutics
- clinical applications of AMPs
- combinatory therapy
